EGFR and neoplasm: Most CTC detection techniques rely on antibody-based capture and staining of cytokeratins and tumor-specific antigens like EpCAM, EphB4, EGFR (Her/ErbB1), HER2, CEA/CEACAM5, and MUC-1.6 No single antibody is sufficient to capture and detect all rare CTCs.